Addex Therapeutics Ltd
ADXN · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $7,062 | $5,380 | $5,318 | $5,180 |
| - Cash | $2,187 | $2,301 | $2,825 | $3,342 |
| + Debt | $37 | $38 | $40 | $42 |
| Enterprise Value | $4,912 | $3,118 | $2,533 | $1,880 |
| Revenue | $30 | $36 | $0 | $2 |
| % Growth | -18.3% | – | -100% | – |
| Gross Profit | $30 | -$198 | $0 | $2 |
| % Margin | 100% | -544.5% | – | 100% |
| EBITDA | -$1,575 | -$1,956 | -$1,470 | -$1,165 |
| % Margin | -5,297.5% | -5,377.2% | – | -77,224.3% |
| Net Income | -$1,577 | -$1,841 | -$1,473 | -$1,206 |
| % Margin | -5,306.3% | -5,061.6% | – | -79,956% |
| EPS Diluted | -1.2 | -2.4 | -1.8 | -1.48 |
| % Growth | 50% | -33.3% | -21.6% | – |
| Operating Cash Flow | -$533 | -$420 | -$599 | -$24 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$533 | -$420 | -$599 | -$24 |